Literature DB >> 2521768

Patterns of cardiac care in infants with Down syndrome.

D S Schneider1, K G Zahka, E B Clark, C A Neill.   

Abstract

To determine if the pattern of cardiac care is affected by the presence of Down syndrome (DS) we analyzed the records of infants enrolled in the Baltimore-Washington Infant Study, a regional case-control study of congenital cardiovascular malformations. The age at cardiac diagnosis, the timing of cardiac surgery, and the one-year outcome were compared in 160 infants with DS and 540 infants with the same cardiac diagnoses but without chromosomal or other extracardiac anomalies (Isolated cardiovascular malformation [ICM] group). Cardiac referral and diagnosis were accomplished by 13 weeks of age in 78% of infants with DS and 67% of those with ICMs. However, by 26 weeks of age, the proportion of infants in both groups was comparable. Cardiac surgery was performed before 1 year of age in 99 of 160 infants with DS and in 141 of 540 infants with ICMs. The surgical outcome was similar in the two groups. We conclude that for defects of comparable severity, the pattern of cardiac care in the Baltimore-Washington, DC, area for infants with DS is timely and comparable to care for infants with ICMs.

Entities:  

Mesh:

Year:  1989        PMID: 2521768     DOI: 10.1001/archpedi.1989.02150150121030

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  3 in total

Review 1.  Optimal care for children with Down syndrome in India.

Authors:  I C Verma; M Kabra; A K Gangakhedkar
Journal:  Indian J Pediatr       Date:  1996 Jan-Feb       Impact factor: 1.967

2.  The effect of changing attitudes to Down's syndrome in the management of complete atrioventricular septal defects.

Authors:  K Amark; J Sunnegårdh
Journal:  Arch Dis Child       Date:  1999-08       Impact factor: 3.791

3.  Down's syndrome affects results of surgical correction of complete atrioventricular canal.

Authors:  C D Morris; D Magilke; M Reller
Journal:  Pediatr Cardiol       Date:  1992-04       Impact factor: 1.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.